Health

Scholars consider how the Modernization of Cosmetics Regulation Act strengthens federal oversight.  

Personal importation is the fastest route to “most-favored-nation” drug pricing.

States can continue to support access to health care, but their efforts depend on federal support.

Scholars discuss policy approaches to lowering the price of prescription drugs.

Scholar proposes reforms to address deficiencies in FDA’s premarket review powers.

Scholars propose changes to patent disclosures under the Biologics Price Competition and Innovation Act.

Mitch Zeller discusses the challenges of regulating to protect the public’s best interest.

Anna Wexler explains “do-it-yourself medicine” and how regulators can protect consumers using at-home medical therapies.

Scholars argue that the Department of Labor should exercise its overlooked authority to regulate health care plan fiduciaries.

Angus Corbett explores how using comparative analysis of health care systems can inform U.S. health care policy.

Scholars analyze the impact of ACA provisions on the gap between part-time and full-time workers’ health insurance coverage

The Trump Administration’s definition of biological sex does not accurately reflect modern science.